dr. andre on nivolumab plus ipilimumab in dmmr/msi-h mcrc
Published 6 years ago • 98 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
5:37
nivolumab plus ipilimumab improves on chemo in previously untreated msi-h/dmmr mcrc
-
1:08
dr. overman discusses nivolumab in patients with dmmr/msi h mcrc
-
2:00
checkmate 8hw: first-line nivolumab plus ipilimumab in msi-h/dmmr mcrc
-
0:59
checkmate 8hw: hrqol outcomes of nivolumab and ipilimumab in msi-h/dmmr mcrc
-
2:00
dr. overman on nivolumab and ipilimumab in patients with msi-h crc
-
2:02
hrqol findings from checkmate 8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
1:11
nivolumab/ipilimumab combination data promising in msi-h/dmmr mcrc
-
5:19
i-o therapy in mcrc: ipilimumab nivolumab
-
1:11
remaining questions for the treatment of patients with msi/dmmr mcrc with immunotherapy
-
1:03
dr. nelson on the checkmate-142 trial in msi-h/dmmr mcrc
-
5:20
pembrolizumab improves on chemo in msi-h/dmmr mcrc
-
1:42
dr. overman on the impact of nivolumab in mcrc
-
3:24
checkmate 8hw: nivolumab plus ipilimumab versus chemotherapy for metastatic colorectal cancer
-
1:05
nivolumab and ipilimumab combination in frontline mcrc
-
1:04
dr. halfdanarson on the keynote-177 trial in msi-h/dmmr mcrc
-
1:02
dr. hodi on nivolumab in combination with ipilimumab for advanced melanoma
-
1:25
dr. ott discusses ipilimumab and nivolumab in melanoma
-
1:08
dr. ahn on the keynote-177 trial in newly diagnosed msi-h/dmmr mcrc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc